Catherine Novack

Stock Analyst at Jones Trading

(0.43)
# 2443
Out of 5,329 analysts
23
Total ratings
33.33%
Success rate
-0.16%
Average return
19 Stocks
Name Action PT Current % Upside Ratings Updated
RGLS Regulus Therapeutics
Downgrades: Hold
8 7
7.85 -10.83% 2 Apr 30, 2025
RLYB Rallybio
Downgrades: Hold
n/a
n/a n/a 1 Apr 15, 2025
PVLA Palvella Therapeutic...
Initiates Coverage On: Buy
45
24.03 87.27% 1 Mar 25, 2025
PRQR ProQR Therapeutics
Initiates Coverage On: Buy
11
1.72 539.53% 1 Feb 12, 2025
KRRO Korro Bio
Initiates Coverage On: Buy
130
18.54 601.19% 1 Nov 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
40
12.82 212.01% 1 Nov 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 1 Nov 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 1 Oct 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
12 16
7.92 102.02% 2 Sep 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
14
2.85 391.23% 1 Sep 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
5 13
2.96 339.19% 2 Aug 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
10
3.96 152.53% 1 Apr 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
7 10
1.18 747.46% 1 Mar 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
22
1.54 1328.57% 1 Feb 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 2 Oct 5, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
160
2.35 6708.51% 1 Jul 21, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
11
n/a n/a 1 Mar 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
25
n/a n/a 1 Dec 2, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
45
n/a n/a 1 Oct 4, 2021